Role of topical therapy in the treatment of moderate to severe psoriasis

被引：0
|
作者：
Feldman, S. [1 ]
机构：
[1] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA
来源：
EADV: Proceedings of the 15th Congress of the European Academy of Dermatology and Venereology | 2006年
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：763 / 768
页数：6
相关论文
共 50 条
  • [21] The use of methotrexate in treatment of moderate to severe psoriasis
    Leung, W. Y.
    Lau, K. H.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2009, 17 (01): : 13 - 19
  • [22] Treatment changes in patients with moderate to severe psoriasis
    Anderson, Kathryn
    Feldman, Steven
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB256 - AB256
  • [23] Update on risankizumab for the treatment of moderate to severe psoriasis
    Al-Janabi, A.
    Warren, R. B.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (11) : 1245 - 1251
  • [24] Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis
    Li, Wendy
    Ghamrawi, Rima
    Haidari, Wasim
    Feldman, Steven R.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (04) : 380 - 387
  • [25] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [26] TOPICAL CORTICOSTEROID-THERAPY FOR SEVERE SCALP PSORIASIS
    BRENEMAN, DL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 128 - 128
  • [27] The role of topical therapy for patients with extensive psoriasis
    Feldman, Steven R.
    Gelfand, Joel M.
    Gold, Linda Stein
    Jones, Sherri D.
    CUTIS, 2007, 79 (01): : 18 - 31
  • [28] Etanercept and methotrexate combination therapy for the treatment of moderate to severe psoriasis: A retrospective multicentre study
    Munoz-Santos, Carlos
    Vidal, David
    Gomez-Vazquez, Mercedes
    Sola-Ortigosa, Joaquim
    Guilabert, Antonio
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 (04) : E147 - E148
  • [29] Adalimumab treatment for moderate psoriasis reduces the risk of transitioning to severe psoriasis
    Papp, Kim
    Signorovitch, James
    Mulani, Parvzez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB181 - AB181
  • [30] Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis
    de Miguel, Rebeca
    el-Azhary, Rokea
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (06) : 653 - 658
12345